郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Corrigendum to "PKC-δ-dependent mitochondrial ROS attenuation is involved as 9-OAHSA combats lipoapotosis in rat hepatocytes induced by palmitic acid and in Syrian hamsters induced by high-fat high-cholesterol high-fructose diet" [Toxicology and Appl

期刊：Toxicology and applied pharmacology发表年份：2023作者：Ching-Hui Loh; Wei-Wen Kuo; Shinn-Zong Lin; Cheng-Yen Shih; Pi-Yu Lin; Jiro Hasegawa Situmorang; Chih-Yang Huang
阅读更多 →

药效评价An automated, low volume, and high-throughput analytical platform for aggregate quantitation from cell culture media.

期刊：Journal of chromatography. A发表年份：2023作者：Giulia Lambiase; Kerensa Klottrup-Rees; Clare Lovelady; Salma Ali; Samuel Shepherd; Maurizio Muroni; Vivian Lindo; David C James; Mark J Dickman
阅读更多 →

药效评价Investigating material basis and molecular mechanism of Qing Cuo formula in the treatment of acne based on animal experiments, UPLC-LTQ-Orbitrap-MS and network pharmacology.

期刊：Pharmaceutical biology发表年份：2023作者：Yanqi Cao; Jinfeng Liang; Chunguo Wang; Xuejie Bao; Siqi Li; Qi Liu; Bin Zeng; David Humberto Lopez; Ruoxi Yu
阅读更多 →

药效评价STAR-0215 is a Novel, Long-Acting Monoclonal Antibody Inhibitor of Plasma Kallikrein for the Potential Treatment of Hereditary Angioedema.

期刊：The Journal of pharmacology and experimental therapeutics发表年份：2023作者：Vahe Bedian; Nikolaos Biris; Charles Omer; Jou-Ku Chung; James Fuller; Rafif Dagher; Sachin Chandran; Peter Harwin; Tomas Kiselak; Jonathan Violin; Andrew Nichols; Pradeep Bista
阅读更多 →